Experienced in Hemolytic Anemia

Josee Brossard

CHU Sainte Justine
Montreal, QC, CA 
Experienced in Hemolytic Anemia
CHU Sainte Justine
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Josee Brossard practices in Montreal, Canada. Ms. Brossard is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Medulloblastoma, Aase Syndrome, Pure Red Cell Aplasia, and Childhood Acute Myeloid Leukemia.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Hemolytic Anemia.

Gender
Female

Locations

CHU Sainte Justine
Montreal, QC, Canada
Other Locations
Sherbrooke, QC J1N3C6, Canada
CHU de Sherbrooke, Univesité de Sherbrooke, Québec
Sherbrooke, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2025
Intervention Type: Drug, Biological, Radiation
Study Drugs: Erwinia Asparaginase, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3

35 Total Publications

Calling to Safeguard the Future of Classical Hematology.
Calling to Safeguard the Future of Classical Hematology.
Journal: Pediatric blood & cancer
Published: April 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Brossard's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile